Argent Capital Management Portfolio holdings
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$35.5M |
| 2 |
LPL Financial
LPLA
|
+$16.8M |
| 3 |
Automatic Data Processing
ADP
|
+$12.2M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$3.62M |
| 5 |
Union Pacific
UNP
|
+$3.6M |
Top Sells
| 1 |
Boston Scientific
BSX
|
+$38M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$26.7M |
| 3 |
Biogen
BIIB
|
+$16M |
| 4 |
Intel
INTC
|
+$9.59M |
| 5 |
Apple
AAPL
|
+$7.8M |
Sector Composition
| 1 | Technology | 22.27% |
| 2 | Financials | 18.97% |
| 3 | Healthcare | 12.74% |
| 4 | Consumer Staples | 12.56% |
| 5 | Communication Services | 11.2% |
Similar funds
Argent Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Argent Capital Management held 205 positions worth $2.81B, up 7.5% from $2.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Argent Capital Management withdrew a net $166M in Q4 2020, closing 12 positions and reducing 102 holdings. Its most notable exit was Boston Scientific, an estimated $38M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Argent Capital Management opened a new position in Schwab US Large- Cap ETF worth $667K.
- Argent Capital Management's largest Q4 2020 buy was Schwab US Large- Cap ETF: 43,980 shares worth $667K.
- Argent Capital Management added most to Berkshire Hathaway Class B in Q4 2020, an estimated $35.5M increase.
- Argent Capital Management's biggest Q4 2020 reduction was Fiserv Inc, cutting an estimated $26.7M.
- Argent Capital Management fully exited Boston Scientific in Q4 2020, selling an estimated $38M.
- Argent Capital Management's ten largest holdings make up 37% of its $2.81B portfolio in Q4 2020.
- Argent Capital Management opened 6 new positions and closed 12 in Q4 2020.
- Argent Capital Management's portfolio value rose 7.5% quarter-over-quarter to $2.81B.
Based on Argent Capital Management's 13F filing for Q4 2020, filed 10 Feb 2021.